Federal probe finds problems with chelation study

Jul 02, 2009 By MARILYNN MARCHIONE , AP Medical Writer

(AP) -- A federal investigation has found problems with a controversial study of an alternative medicine treatment for heart attack victims.

A report from the U.S. Office for Human Research Protections says people in the study were not told enough about the potential dangers of the treatment, called chelation ("kee-LAY'shun"). The report says some doctors involved in the study have been disciplined by state medical boards, and at least three are convicted felons.

The government is letting the study go on while the probe continues.

©2009 The Associated Press. All rights reserved. This material may not be published, broadcast, rewritten or redistributed.

Explore further: Determine patient preferences by means of conjoint analysis

add to favorites email to friend print save as pdf

Related Stories

Which treatment works best? Top study needs listed

Jun 30, 2009

(AP) -- The government is about to start a huge research effort to prove which are the best treatments for scores of ailments. Irregular heartbeat, prostate cancer, back pain and hearing loss lead the list of medical problems ...

Swine flu cases up to 7, probe expanding

Apr 23, 2009

(AP) -- Health officials say a unique type of swine flu has now been diagnosed in seven people in California and Texas, up from the two reported earlier this week. The five new cases in the two states have all recovered, ...

US swine flu victims had chronic health problems

May 07, 2009

(AP) -- Health officials have released details about the chronic health problems suffered by the two people who died from swine flu in the United States. The Mexican toddler who died in Texas suffered from ...

Mexico City closes museums to stop flu outbreak

Apr 24, 2009

(AP) -- Mexico's federal government has closed museums, libraries, and state-run theaters as well as schools in its overcrowded capital to stop a swine flu outbreak authorities say may have killed as many ...

Recommended for you

Determine patient preferences by means of conjoint analysis

1 hour ago

The Conjoint Analysis (CA) method is in principle suitable to find out which preferences patients have regarding treatment goals. However, to widely use it in health economic evaluations, some (primarily methodological) issues ...

FDA approves hard-to-abuse narcotic painkiller

Jul 25, 2014

(HealthDay)—A new formulation of a powerful narcotic painkiller that discourages potential abusers from snorting or injecting the drug has been approved by the U.S. Food and Drug Administration.

Race affects opioid selection for cancer pain

Jul 25, 2014

(HealthDay)—Racial disparities exist in the type of opioid prescribed for cancer pain, according to a study published online July 21 in the Journal of Clinical Oncology.

FDA approves tough-to-abuse formulation of oxycodone

Jul 25, 2014

(HealthDay)—Targiniq ER (oxycodone hydrochloride and naloxone hydrochloride extended release) has been approved by the U.S. Food and Drug Administration as a long-term, around-the-clock treatment for severe ...

Tough-to-abuse formulation of oxycodone approved

Jul 25, 2014

(HealthDay)—Targiniq ER (oxycodone hydrochloride and naloxone hydrochloride extended release) has been approved by the U.S. Food and Drug Administration as a long-term, around-the-clock treatment for severe pain when other ...

User comments : 4

Adjust slider to filter visible comments by rank

Display comments: newest first

deatopmg
2 / 5 (4) Jul 02, 2009
What study? What are the details? Who is sponsoring it? What are protocols? Will/have they be(en) changed at the last minute to make the study fail, as in past "studies"?

This is an empty article.
E_L_Earnhardt
1 / 5 (1) Jul 02, 2009
CHELATION is a useful process to remove certain chemicals in the blood stream. I doubt it has any use in cellure treatment and could be dangerous! I agree with "deatopmg"!
hrfJC
1.8 / 5 (5) Jul 03, 2009
If this study design is indeed as flawed as described and conducted by convicted medical villains, why is it allowed to continue? Or is this PR merely an anticipated FDA verdict of "ineffective or dangerous" in order to write off chelation once and for all as a lower cost alternative to highly profitable FDA approved therapies that are often more prone to adverse effects.
ToddC
5 / 5 (1) Jul 03, 2009
What a miserable piece of "reporting" on Physorg - didn't anyone review this article? Here is the link to the blog entry by the writer: http://www.newsvi...on-study